Skip to main content
Clinical Trials/NCT03157440
NCT03157440
Completed
Not Applicable

Validation of a Novel Device for Screening Patients With Symptoms of OSA

Chinese University of Hong Kong1 site in 1 country97 target enrollmentApril 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep Apnea Syndromes
Sponsor
Chinese University of Hong Kong
Enrollment
97
Locations
1
Primary Endpoint
the concordance of the ring oximetry with PSG as the gold standard
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

An innovative ring type oxymetry will be wore by patient undergoing sleep study to validate it's accuracy and usefulness as a screening device for patients with symptoms of OSA

Registry
clinicaltrials.gov
Start Date
April 1, 2017
End Date
March 31, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

To Kin Wang

Doctor

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Patients above 18 years old and below 70 years old, both men and women

Exclusion Criteria

  • Patients requiring oxygen therapy or noninvasive ventilation;
  • Patients with a diagnosis of chronic obstructive pulmonary disease, chronic heart failure, neuromuscular disease, insomnia, clinical symptoms of parasomnia, periodic limb movement, or narcolepsy.
  • Patients on medication known to interfere with heart rate, such as beta-blockers, digoxin or calcium receptor antagonists.

Outcomes

Primary Outcomes

the concordance of the ring oximetry with PSG as the gold standard

Time Frame: 1 year

Study Sites (1)

Loading locations...

Similar Trials